Professor, Molecular Medicine, Case Western Reserve University School of Medicine
Internal Medicine
Dr. Stanley L. Hazen, MD
|
|
Give Review
Stanley Hazen practices Internal Medicine. He received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Elected Member" and "Fellow (FACC)". Stanley L. Hazen, MD has written publications. He has 65 publications published with PubMed. The lastest paper is: 'Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.' He is registered with Medicare and accepts Medicare payments.
Publications
- Usefulness of Relative Hypochromia in Risk Stratification for Nonanemic Patients With Chronic Heart Failure.
- Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.
- Arsenic induces structural and compositional colonic microbiome change and promotes host nitrogen and amino acid metabolism.
- HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function.
- Transmission of atherosclerosis susceptibility with gut microbial transplantation.
- Oxidation increases mucin polymer cross-links to stiffen airway mucus gels.
- Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis.
- Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
- The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance.
- Prognostic value of elevated serum ceruloplasmin levels in patients with heart failure.
- Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.
- Biomarker-based asthma phenotypes of corticosteroid response.
- γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO.
- Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
- Intestinal Microbiota-Dependent Phosphatidylcholine Metabolites, Diastolic Dysfunction and Adverse Clinical Outcomes in Chronic Systolic Heart Failure.
- Dual Role of the Leukocyte Integrin αMβ2 in Angiogenesis.
- Prognostic Comparison of Different Sensitivity Cardiac Troponin Assays in Stable Heart Failure.
- Target-selective protein s-nitrosylation by sequence motif recognition.
- Prognostic Value of Estimating Functional Capacity Using the Duke Activity Status Index in Stable Patients with Chronic Heart Failure.
- Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease.
- Usefulness of elevated urine neopterin levels in assessing cardiac dysfunction and exercise ventilation inefficiency in patients with chronic systolic heart failure.
- Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.
- Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry.
- Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression.
- Comparative Genome-Wide Association Studies in Mice and Humans for Trimethylamine N-Oxide, a Proatherogenic Metabolite of Choline and L-Carnitine.
- Breathprints of childhood obesity: changes in volatile organic compounds in obese children compared with lean controls.
- An abundant dysfunctional apolipoprotein A1 in human atheroma.
- Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: Insights from intravascular ultrasound.
- Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
- Metaorganismal nutrient metabolism as a basis of cardiovascular disease.
- The susceptibility of bioprosthetic heart valve leaflets to oxidation.
- OxNASH Score Correlates with Histologic Features and Severity of Nonalcoholic Fatty Liver Disease.
- High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies.
- Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects.
- Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.
- Kindlin-2 regulates hemostasis by controlling endothelial cell surface expression of ADP/AMP catabolic enzymes via a clathrin-dependent mechanism.
- Protein carbamylation predicts mortality in ESRD.
- Genome-wide and Gene-Centric Analyses of Circulating Myeloperoxidase Levels in the CHARGE and CARe Consortia.
- Protein carbamylation in chronic systolic heart failure: relationship with renal impairment and adverse long-term outcomes.
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis.
- Aspirin Hydrolysis in Plasma Is a Variable Function of Butyrylcholinesterase and Platelet-activating Factor Acetylhydrolase 1b2 (PAFAH1b2).
- The low-resolution structure of nHDL reconstituted with DMPC with and without cholesterol reveals a mechanism for particle expansion.
- Quantification of fatty acid oxidation products using on-line high performance liquid chromatography tandem mass spectrometry.
- Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: relation to severity of cardiac dysfunction.
- Detectable Subclinical Myocardial Necrosis Is Associated With Cardiovascular Risk in Stable Patients With Diabetes Mellitus.
- Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure.
- Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease.
- Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation.
- Usefulness of Cardiac Biomarker Score for Risk Stratification in Stable Patients Undergoing Elective Cardiac Evaluation Across Glycemic Status.
- High-density lipoprotein function, dysfunction, and reverse cholesterol transport.
- Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk.
- Immunoglobulins against tyrosine-nitrated epitopes in coronary artery disease.
- Protection of Extraribosomal RPL13a by GAPDH and Dysregulation by S-Nitrosylation.
- Pilot candidate gene analysis of patients ≥ 60 years old with aortic stenosis involving a tricuspid aortic valve.
- Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension.
- Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminoh...
- Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure.
- Jupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?
- Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function.
- Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure.
- Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB.
- The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases.
- Prognostic value of estimated functional capacity incremental to cardiac biomarkers in stable cardiac patients.
- Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.
Schools
Washington Center School of Medicine
Barnes Jewish Hospital
Washington University
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
- Fellow (FACC)
Education
-
Washington University - Barnes-Jewish Hospital
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1922195783 | |
| NPPES Provider LastName | HAZEN | |
| NPPES Provider FirstName | STANLEY | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Cardiology | |
| Total Claim Count | 120.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1922195783 |
| Last Name Of The Provider | HAZEN |
| First Name Of The Provider | STANLEY |
| View All |
Similar Doctors
|
|
Dr. Jeanne T. Zuber, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kareem R. Elder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Saaransh R. Desai, MD |
|
|
Dr. Mihail T. Paxos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Iryna Babych, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nezar S. Zamzam, MD |
|
|
Dr. Zeina S. Ibrahim, MD |
|
|
Abdullah M. Alghamdi |